People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inhibitex, Inc. | — | Biotechnology | Series B | $23.0M | $912.9M | 2009 |
Chris M. McGuigan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris M. McGuigan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gabriele M. Cerrone | 1 | 2 |
| M. James M. Barrett | 1 | 1 |
| Russell M. Medord | 1 | 1 |
| Marc L. Preminger | 1 | 1 |
| Joseph M. Patti | 1 | 1 |
| Geoffrey W. Henson | 1 | 1 |
| A. Keith L. Willard | 1 | 1 |
| Michael M. Henos | 1 | 1 |
| Russell H. Plumb | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.